|
|
Volumn 39, Issue 3, 2000, Pages 185-201
|
|
Comparative pharmacokinetics of the carbapenems: Clinical implications
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
6 (1 HYDROXYETHYL) 2 [2 (3 METHANESULFONYLAMINO 1 PROPENYL) 4 PYRROLIDINYLTHIO] 1 METHYL 1 CARBAPEN 2 EM 3 CARBOXYLIC ACID;
6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID;
6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER;
6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 [1 (2 THIAZOLIN 2 YL) 3 AZETIDINYLTHIO] 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID;
BIAPENEM;
CARBAPENEM DERIVATIVE;
CILASTATIN PLUS IMIPENEM;
DEHYDROPEPTIDASE I;
DIETHYLCARBAMAZINE;
DORIPENEM;
E 1010;
ERTAPENEM;
IMIPENEM;
KR 21012;
KR 21056;
LENAPENEM;
MEROPENEM;
PANIPENEM;
PANIPENEM PLUS BETAMIPRON;
PEPTIDASE;
UNCLASSIFIED DRUG;
VALPROIC ACID;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL ACTIVITY;
ANTIMICROBIAL THERAPY;
BACTERIAL INFECTION;
COMPARATIVE STUDY;
CONTINUOUS INFUSION;
CONVULSION;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG SENSITIVITY;
DRUG STRUCTURE;
HUMAN;
LIVER TOXICITY;
MINIMUM INHIBITORY CONCENTRATION;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
STRUCTURE ACTIVITY RELATION;
CARBAPENEMS;
DRUG INTERACTIONS;
HUMAN;
KIDNEY FAILURE;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 0033804883
PISSN: 03125963
EISSN: None
Source Type: Journal
DOI: 10.2165/00003088-200039030-00002 Document Type: Review |
|
Times cited : (177)
|
|
References (3)
|
